| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |